Skip to main content

Table 2 Effect of DOX and/or RSVL on the growth of MCF-7 cells

From: Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line

Treatment

IC50 (μg/ml)

DOX

0.417 ± 0.107

DOX + RSVL (15 μg/ml) (supplied simultaneously)

0.056a ± 0.026

DOX + RSVL (15 μg/ml) (RSVL supplied 24 h before DOX)

0.035a,b ± 0.016

  1. IC50: the concentration of DOX necessary to produce 50% inhibition of cell growth.
  2. a Significantly different from DOX at P-value < 0.05.
  3. b Significantly different from DOX+ RSVL (Simultaneously) at P-value < 0.05.